222 related articles for article (PubMed ID: 20844469)
1. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.
Gutiérrez-Dalmau A; Revuelta I; Ferrer B; Mascaró JM; Oppenheimer F; Albanell J; Campistol JM
Transplantation; 2010 Nov; 90(9):986-92. PubMed ID: 20844469
[TBL] [Abstract][Full Text] [Related]
2. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.
Fortina AB; Piaserico S; Caforio AL; Abeni D; Alaibac M; Angelini A; Iliceto S; Peserico A
Arch Dermatol; 2004 Sep; 140(9):1079-85. PubMed ID: 15381547
[TBL] [Abstract][Full Text] [Related]
5. Immune phenotype of peripheral blood cells and skin squamous cell carcinoma in organ transplant recipients.
Dziunycz P; Hofbauer GF
Expert Rev Clin Immunol; 2010 May; 6(3):359-62. PubMed ID: 20441422
[TBL] [Abstract][Full Text] [Related]
6. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
7. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
Zamanian A; Farshchian M
J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
[TBL] [Abstract][Full Text] [Related]
9. p53-specific serum antibodies are not associated with a history of skin carcinoma in renal transplant recipients and immunocompetent individuals.
de Graaf YG; Schiefer D; Redeker A; Vermeer BJ; Bavinck JN; Willemze R; de Gruijl FR; Van der Burg SH
J Dermatol Sci; 2005 Jun; 38(3):228-30. PubMed ID: 15927816
[No Abstract] [Full Text] [Related]
10. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
11. Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study.
Savoia P; Stroppiana E; Cavaliere G; Osella-Abate S; Mezza E; Segoloni GP; Bernengo MG
Eur J Dermatol; 2011; 21(2):242-7. PubMed ID: 21382788
[TBL] [Abstract][Full Text] [Related]
12. Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients.
Perera GK; Child FJ; Heaton N; O'Grady J; Higgins EM
Br J Dermatol; 2006 May; 154(5):868-72. PubMed ID: 16634888
[TBL] [Abstract][Full Text] [Related]
13. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern.
Keller B; Braathen LR; Marti HP; Hunger RE
Swiss Med Wkly; 2010; 140():w13036. PubMed ID: 20652847
[TBL] [Abstract][Full Text] [Related]
14. Subsequent nonmelanoma skin cancers and impact of immunosuppression in liver transplant recipients.
Funk-Debleds P; Ducroux E; Guillaud O; Ursic-Bedoya J; Decullier E; Vallin M; Euvrard S; Pageaux GP; Boillot O; Dumortier J
J Am Acad Dermatol; 2018 Jul; 79(1):84-91. PubMed ID: 29307647
[TBL] [Abstract][Full Text] [Related]
15. Basal cell carcinoma in a series of renal transplant recipients: epidemiology and clinicopathologic features.
Mertz KD; Proske D; Kettelhack N; Kegel C; Keusch G; Schwarz A; Ambühl PM; Pfaltz M; Kempf W
Int J Dermatol; 2010 Apr; 49(4):385-9. PubMed ID: 20465691
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous manifestations in renal transplant recipients of Santiago, Chile.
Sandoval M; Ortiz M; Díaz C; Majerson D; Molgó M
Transplant Proc; 2009 Nov; 41(9):3752-4. PubMed ID: 19917380
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous neoplasms in renal transplant recipients.
Rubel JR; Milford EL; Abdi R
Eur J Dermatol; 2002; 12(6):532-5. PubMed ID: 12459521
[TBL] [Abstract][Full Text] [Related]
18. Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN; Vermeer BJ; van der Woude FJ; Vandenbroucke JP; Schreuder GM; Thorogood J; Persijn GG; Claas FH
N Engl J Med; 1991 Sep; 325(12):843-8. PubMed ID: 1875968
[TBL] [Abstract][Full Text] [Related]
19. Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients.
Krynitz B; Lundh Rozell B; Lindelöf B
Acta Derm Venereol; 2010 Jul; 90(4):379-85. PubMed ID: 20574603
[TBL] [Abstract][Full Text] [Related]
20. Ocular surface squamous neoplasia in a renal transplant recipient on immunosuppressive therapy.
Shome D; Honavar SG; Manderwad GP; Vemuganti GK
Eye (Lond); 2006 Dec; 20(12):1413-4. PubMed ID: 16470219
[No Abstract] [Full Text] [Related]
[Next] [New Search]
